carvedilol has been researched along with Hepatocellular Carcinoma in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Collectively, in HA59T hepatoma cells, carvedilol induced [Ca2+]i rises by causing Ca2+ release from the endoplasmic reticulum in a phospholipase-C-independent manner and Ca2+ influx via store-operated Ca2+ channels." | 1.34 | Mechanisms of carvedilol-induced [Ca2+] i rises and death in human hepatoma cells. ( Cheng, JS; Chou, CT; Huang, CC; Jan, CR, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sinha, R | 1 |
| Cheng, JS | 1 |
| Huang, CC | 1 |
| Chou, CT | 1 |
| Jan, CR | 1 |
2 other studies available for carvedilol and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Exploring the potential chemoprophylactic role of carvedilol for hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Carvedilol; Humans; Liver Neoplasms | 2022 |
Mechanisms of carvedilol-induced [Ca2+] i rises and death in human hepatoma cells.
Topics: Adrenergic beta-Antagonists; Apoptosis; Calcium; Carbazoles; Carcinoma, Hepatocellular; Carvedilol; | 2007 |